Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
10.15430/JCP.2021.26.4.309
- Author:
Altaf MOHAMMED
1
;
Roderick H. DASHWOOD
;
Sally DICKINSON
;
Mary L. DISIS
;
Elizabeth M. JAFFEE
;
Bryon D. JOHNSON 6
;
Samir N. KHLEIF
;
Michael N. POLLAK
;
Jeffrey SCHLOM
;
Robert H. SHOEMAKER
;
Sasha E. STANTON
;
Georg T. WONDRAK
;
Ming YOU
;
Hao ZHU
;
Mark Steven MILLER
Author Information
1. Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA
- Publication Type:Meeting Report
- From:Journal of Cancer Prevention
2021;26(4):309-317
- CountryRepublic of Korea
- Language:English
-
Abstract:
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.
